Blog Archive

Search This Blog

Monday, November 19, 2018

The Glycerin Associated Pain (GAP) Study

Fifty percent glycerin is often used in allergen immunotherapy (AIT) extracts to preserve extract potency.1 However, glycerin is also an irritant and it is recommended to dilute glycerin to reduce pain and inflammation associated with immunotherapy.2, 3 The 2011 allergen immunotherapy practice parameter warns that "higher glycerin concentrations are associated with injection pain, which correlates with the total amount of glycerin injected."4 To date, two studies evaluating the role of glycerin during allergen immunotherapy differed regarding their methods and conclusions.

from Allergy and Immunology via a.sfakia on Inoreader https://ift.tt/2qT9X6e

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...